Acrivon Therapeutics News

Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Acrivon Therapeutics, Inc. (ACRV)

TipRanksApr 27 20:10

Acrivon Therapeutics Analyst Ratings

BenzingaApr 27 02:01

Piper Sandler Adjusts Price Target on Acrivon Therapeutics to $30 From $26, Keeps Overweight Rating

MT NewswiresApr 25 21:32

Piper Sandler Maintains Overweight on Acrivon Therapeutics, Raises Price Target to $30

BenzingaApr 25 20:53

HC Wainwright & Co. : The Acrivon Therapeutics (ACRV.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $20.00.

Zhitong FinanceApr 25 19:30

Acrivon Therapeutics Analyst Ratings

BenzingaApr 25 19:27

HC Wainwright & Co. Reiterates Buy on Acrivon Therapeutics, Maintains $20 Price Target

BenzingaApr 25 19:29

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)

TipRanksApr 25 18:30

Acrivon Therapeutics: A Buy Rating With Promising Clinical and Market Outlook

TipRanksApr 22 22:45

Piper Sandler Remains a Buy on Acrivon Therapeutics, Inc. (ACRV)

TipRanksApr 17 19:15

Buy Rating Affirmed for Acrivon Therapeutics on Promising Drug Pipeline and Solid Financials

TipRanksApr 11 02:55

Acrivon Therapeutics: Strategic Finance and Clinical Promise Merit a Buy Rating

TipRanksApr 9 23:15

Acrivon Therapeutics Analyst Ratings

BenzingaApr 5 22:39

Analysts Are Bullish on These Healthcare Stocks: Acrivon Therapeutics, Inc. (ACRV), Abivax SA Sponsored ADR (ABVX)

TipRanksApr 3 03:40

Acrivon Therapeutics Analyst Ratings

BenzingaApr 2 00:21

JMP Securities Reiterates Market Outperform on Acrivon Therapeutics, Maintains $14 Price Target

BenzingaApr 1 21:13

Buy Rating on Acrivon Therapeutics: Anticipated Clinical Validation and Strong Financial Position

TipRanksApr 1 12:25

Buy Rating Justified by Acrivon Therapeutics' Clinical Progress and Market Potential

TipRanksMar 28 23:55

Acrivon Therapeutics Analyst Ratings

BenzingaMar 2 00:28

Acrivon Therapeutics: A Buy Rating on Revolutionary Precision Medicine Platform and Promising Clinical Trials

TipRanksJan 12 20:15